Investors / Mystic Ventures
Mystic Ventures
Venture capital
Mystic Ventures is a rolling fund, established in 2021, that invests in psychedelic and neuroplastogen medicines for the central nervous system and in the clinical infrastructure required to deliver them. It is open to accredited investors only and operates as a series of quarterly funds.
Invests inHealthcare & Biotech
In its own wordspsychedelicsneurotherapeuticscnsmental healthdrug developmentclinical infrastructure
Your fit with Mystic Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMystic Ventures lists 29 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (79%), Food & Agriculture (9%) and Robotics & Hardware (3%). 85% of its companies are based in United States. It invests most often alongside Iter Investments, PsyMed Ventures and XEIA Venture Partners.
No funding round on record names Mystic Ventures yet, so the figures come from its portfolio page.
Round figures show recent activity, not Mystic Ventures' whole history. Rounds on record name 0 companies; its own site lists 29. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 66th | 29 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 93th | 79% in its largest sector |
| Reach | 58th | 3 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers29100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 79% | 15% |
| Food & Agriculture | 9% | 3% |
| Robotics & Hardware | 3% | 1% |
| Media & Entertainment | 3% | 4% |
| Gaming | 3% | 1% |
| AI & Machine Learning | 3% | 18% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Iter Investments
Compare Mystic Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its sitePortfolio
29 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| 2A Biosciences is developing precision agonists to restore neural circuitry and immune balance | Healthcare & Biotech | Portfolio page | ||
| Breathwrk is a health and performance app helping people to calm down, focus, increase stamina, and fall asleep quickly through breathing exercises and classes. | Healthcare & Biotech | Portfolio page | ||
| CB Therapeutics produces various compounds, including cannabinoids, terpenes, and alkaloids, through precision fermentation in yeast. | Healthcare & BiotechFood & Agriculture | Portfolio page | ||
| DopaGE offers virtual, gamified education designed by emergency medical personnel and neuroscientists to train learners in substance use safety. | Healthcare & Biotech | Portfolio page | ||
| DoubleBlind is a community and media company covering the expansion of psychedelics around the globe. | Media & EntertainmentHealthcare & Biotech | Portfolio page | ||
| Enthea offers employers an innovative way to support employee mental health with cutting-edge, evidence-based therapies | Healthcare & Biotech | Portfolio page | ||
| Equulus Therapeutics develops non-hallucinogenic therapeutics for CNS disorders | Healthcare & Biotech | Portfolio page | ||
| Freedom Biosciences is a biotechnology platform developing next-generation neuropsychiatric therapeutics. | Healthcare & Biotech | Portfolio page | ||
| Bia Neuroscience uses neurofeedback to help people fall asleep, stay asleep, and wake up fresh | Healthcare & Biotech | Portfolio page | ||
| The company provides mental health services, including psychiatry, ketamine treatment, and transcranial magnetic stimulation. | Healthcare & Biotech | Portfolio page | ||
| Journey-Clinical provides ketamine-assisted psychotherapy and other psychedelic treatments for various mental health conditions. | Healthcare & Biotech | Portfolio page | ||
| Adamo Bioscience is a sexual wellness company that provides comprehensive and evidence-based sex therapy, education and tools for deepening human connection and leading a life of sexual ecstasy. | Healthcare & Biotech | Portfolio page | ||
| Lophora is a clinical-stage CNS therapeutics company developing differentiated, next-generation neuroactive medicines designed to induce neuroplasticity and address significant unmet needs in neuropsychiatry | Healthcare & Biotech | Portfolio page | ||
| Mindstate Design Labs designs and develops psychoactive substances using molecular design and engineering techniques. | Healthcare & BiotechRobotics & Hardware | Portfolio page | ||
| The company designs, implements, and manages AI systems to eliminate repetitive administrative work for healthcare practices. | Healthcare & Biotech | Portfolio page | ||
| NEXT Life Sciences provides modern reproductive healthcare to help couples come together. | Healthcare & Biotech | Portfolio page | ||
| Psilera is revolutionizing how small-molecule drug discovery is done through next-generation precision neuroscience | Healthcare & Biotech | Portfolio page | ||
| Psychedelic Water produces relaxation kava water | Food & Agriculture | Portfolio page | ||
| Sama Therapeutics advances precision neuropsychiatry using AI-powered predictive biomarkers and computational neuroscience | Healthcare & Biotech | Portfolio page | ||
| SeedBox Labs provides at-home fertility testing using a device with lab-grade precision and real-time analysis | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- mystic.ventures
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 29
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Mystic Ventures' profile as data
Pull Mystic Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/mystic.ventures
# also
GET /v1/firms/mystic.ventures/portfolio
GET /v1/firms/mystic.ventures/coinvestors
GET /v1/firms/mystic.ventures/news